For Immediate Release
Prodesse, Inc. Appoints David J. Tyler VP, Manufacturing
WAUKESHA, WI (November 23, 2004) - Prodesse, Inc. today announced the appointment of David J. Tyler as Vice President, Manufacturing. He will be in charge of the build out and operation of Prodesse’s new facility for the manufacture of molecular diagnostics products for infectious disease detection.
The most recent addition to Prodesse’s management team, Tyler joins Prodesse from Third Wave Technologies (TWTI, Madison, WI), where he was Director of Manufacturing. At Third Wave, in addition to his manufacturing responsibilities, he was also extensively involved with ISO and cGMP activities, manufacturing software implementation and design controls. Prior to Third Wave, Tyler was QC/Production Manager for Gorilla Genomics (Alameda, CA) where he was instrumental in optimizing the company’s products for use on a variety of Real Time and other platforms. He also developed automated manufacturing facilities at Gorilla as well as several other organizations.
Tyler has previously been affiliated with Lawrence Berkeley National Laboratories, the University of California at San Francisco and Howard Hughes Medical Institute (Berkeley, CA) and has medical training from the School of Medicine at the University of California San Francisco. He has one patent pending and has co-authored two publications. He received his M.S. in Microbiology and B.A. from the University of California, Berkeley.
Tom Shannon, CEO of Prodesse said, "Dave is exactly what we were looking for in an experienced molecular diagnostics professional to join our team. With his extensive experience in manufacturing of molecular diagnostic products and our new manufacturing facility, we expect Dave to be a major contributor immediately. His extensive scientific background will also be of value to us on the R&D side of our business."
About Prodesse
Prodesse is a biotechnology company focused on developing molecular diagnostic reagents for a variety of infectious disease applications. The company’s products are designed based on a combination of Prodesse’s patented technologies and other licensed technologies. Prodesse sells research use only kits worldwide, CE Marked in vitro diagnostic kits outside the US , FDA 510(k) cleared products worldwide and analyte specific reagents in the US . Analyte specific reagents can be used by CLIA certified laboratories to develop assays for detecting infectious organisms. The company’s products can be used on multiple nucleic acid extraction and PCR detection platforms. Prodesse also operates a CLIA certified laboratory for testing services in the Midwest area. For more information about Prodesse and its products, call 888-589-6974 or go to www.prodesse.com.
Press Contact:
Andy Shrago, Chief Marketing Officer
Prodesse, Inc.
Phone: (262) 446-0700
Email: ashrago@prodesse.com